Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.21 million. The enterprise value is $6.90 million.

Market Cap	13.21M
Enterprise Value	6.90M

Important Dates

The next estimated earnings date is Friday, March 20, 2026, after market close.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

MBRX has 3.08 million shares outstanding. The number of shares has increased by 528.05% in one year.

Current Share Class	3.08M
Shares Outstanding	3.08M
Shares Change (YoY)	+528.05%
Shares Change (QoQ)	+135.60%
Owned by Insiders (%)	1.43%
Owned by Institutions (%)	3.45%
Float	3.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.39

Current Ratio	1.39
Quick Ratio	1.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-69.18%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-165.04%
Weighted Average Cost of Capital (WACC)	12.77%
Revenue Per Employee	n/a
Profits Per Employee	-$3.02M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.93% in the last 52 weeks. The beta is 1.62, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-88.93%
50-Day Moving Average	5.43
200-Day Moving Average	13.05
Relative Strength Index (RSI)	42.27
Average Volume (20 Days)	136,766

Short Selling Information

The latest short interest is 358,088, so 11.63% of the outstanding shares have been sold short.

Short Interest	358,088
Short Previous Month	171,538
Short % of Shares Out	11.63%
Short % of Float	11.80%
Short Ratio (days to cover)	2.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.21M
Pretax Income	-51.41M
Net Income	-51.41M
EBITDA	-24.10M
EBIT	-24.21M
Earnings Per Share (EPS)	-$76.14

Balance Sheet

The company has $6.70 million in cash and $390,000 in debt, with a net cash position of $6.31 million or $2.05 per share.

Cash & Cash Equivalents	6.70M
Total Debt	390,000
Net Cash	6.31M
Net Cash Per Share	$2.05
Equity (Book Value)	-26.92M
Book Value Per Share	-13.60
Working Capital	2.20M

Cash Flow

Operating Cash Flow	-22.45M
Capital Expenditures	n/a
Free Cash Flow	-22.45M
FCF Per Share	-$7.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-528.05%
Shareholder Yield	-528.05%
Earnings Yield	-389.19%
FCF Yield	-169.96%

Analyst Forecast

The average price target for MBRX is $105.50, which is 2,359.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$105.50
Price Target Difference	2,359.21%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 1, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Dec 1, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1